In other recent news, Dianthus Therapeutics has completed patient enrollment for its Phase 2 MaGic trial, evaluating the efficacy of DNTH103 in individuals with generalized Myasthenia Gravis.

If you find yourself enchanted by these garden gems, here are a few tips to help you choose the right hydrangea and keep it thriving.

Shares of Dianthus Therapeutics (NASDAQ:DNTH) jumped 5.8% after William Blair initiated coverage on the stock with an Outperform rating, marking the 13th buy recommendation the clinical-stage ...

Three years ago, when Jannik Sinner and Carlos Alcaraz first met at Wimbledon in a round-of-16 fixture, the tennis world was still speaking about them in hushed tones. They were talented and showed ...

Find the latest LENZ Therapeutics, Inc. (LENZ) stock quote, history, news and other vital information to help you with your stock trading and investing.

The first syntheses of the naturally occurring cyclic peptides dianthin I (1), pseudostellarin A (2), and heterophyllin J (3) are described. The linear protected peptide precursors were prepared ...